Figure 1 | Scientific Reports

Figure 1

From: Nintedanib inhibits growth of human prostate carcinoma cells by modulating both cell cycle and angiogenesis regulators

Figure 1

Nintedanib treatment significantly decreased cell viability in both androgen- dependent and -independent human PCa cells. Live cell number and percent of cell death in (a) PC3, (b) DU145, and (c) LNCaP cells after 24, 48 and 72 h of treatment. For live cell number, values are expressed as mean ± S.E.M. (n = 3) and as percentage ± S.E.M for percent of cell death (ANOVA followed by Dunnett’s test), *p < 0.05; **p < 0.01; ***p < 0.001.

Back to article page